5360992
Last Update Posted: 2022-05-04
Recruiting has ended
All Genders accepted | 18 Years + |
1200 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Pulmonary Embolism: Mechanism and Therapeutic Innovation
To explore the pathogenesis, therapy and outcome of pulmonary embolism (PE) and chronic thromboembolic pulmonary hypertension (CTEPH).
The study recruited consecutive outpatients or hospitalized patients diagnosed with pulmonary embolism (PE cohort) and chronic thromboembolic pulmonary hypertension (CTEPH cohort). The follow-up of all patients was performed annually by phone or outpatient visit. The main outcomes were bleeding, recurrent events, and survival. The objective of the study was to explore the pathogenesis, therapy and outcome of PE and CTEPH.
Eligibility
Relevant conditions:
Pulmonary Embolism
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov